ABSTRACT. Two cats with abdominal effusion and anorexia were diagnosed as feline infectious peritonitis (FIP). We tried to evaluate the effect of thromboxane (Tx) synthetase inhibitor, ozagrel hydrochloride, on the progression of symptoms and clinicopathologic data characteristic to FIP. After administration of Tx synthetase inhibitor, improvement of appetite and activity, decreases of peritoneal effusion, reduction of leukocyte number to normal level, and improvement of hyper γ-globulinemia were found in 2 cats with FIP. These findings suggest that the vasculitis in FIP can be successfully treated with Tx synthetase inhibitor which inhibits platelet aggregation. -KEY WORDS: feline, feline infectious peritonitis (FIP), thromboxane synthetase inhibitor.
to examine whether the inhibition of platelet aggregation could suppress the progression of FIP in cats. This report deals with the effect of Tx synthetase inhibitor on the disease progression in 2 spontaneous cases of FIP.
A 10-month-old female Persian cat, case 1, was admitted with abdominal enlargement and anorexia. Physical examination revealed pale mucous membranes and peritoneal effusion. On the hematological examination (Table 1) , normocytic, normochromic anemia and leukocytosis (34,900/µl) due to neutrophilia (23,380/µl) were indicated. Hyperproteinemia (7.8 g/dl) with polyclonal gammopathy was observed, and A/G ratio was 0.36. On serum chemistry, alanine amino transferase (ALT) level was elevated. On serological examination, level of anti-FIPV antibody titer examined by enzyme-linked immunosorbent assay (ELISA) was relatively high (1:1,600) at the first admission. Radiographic examination revealed severe abdominal effusion (Fig. 1a) . Aspirated peritoneal fluid was yellow in color and contained many neutrophils and macrophages. From these findings, case 1 was diagnosed as FIP. Treatment with ozagrel hydrochloride (5 mg/kg, twice daily) (Kissei Pharmaceutical, Matsumoto, Japan) and Feline infectious peritonitis (FIP) is a progressive and fatal systemic immune-mediated disease of cats caused by a coronavirus, feline infectious peritonitis virus (FIPV) [5, 14] . FIPV causes systemic infection of the macrophage system and induces severe, widespread immune complexmediated vasculitis with necrosis and pyogranulomatous inflammation [14] . Our recent studies on cytokines have indicated some fundamental events in the pathogenesis of FIP [6] [7] [8] 11] . Furthermore, enhanced platelet aggregation is considered to be associated with the progression of the vasculitis [2, 3] . At the time being, no effective treatment has been developed for complete elimination of coronavirus infection [5] , and the every protocol of treatment introduced for FIP has been uneffective in prolongation of life and introduction of remission in cats with the disease.
Thromboxane synthetase inhibitor (ozagrel hydrochloride) suppresses platelet aggregation and production of thromboxane (Tx) A2 that is a strong platelet aggregating agent [12] . It has been shown that administration of Tx synthetase inhibitor reduces urinary protein excretion and increases serum protein concentration to normal range in dogs with glomerulonephritis [9, 10] . Therefore, we tried predonisolone (2 mg/kg/day) was employed for the treatment of this case. Two weeks after initiation with the treatment, improvement in appetite, activity and anemia were observed and abdominal fluids disappeared (Fig. 1b) . At the time, the leukocyte count decreased to 17,800/µl. The concentration of the total protein and γ-globulin in the serum decreased to 7.0 g/dl and 2.1 g/dl respectively. Four months after the first admission, the anti-FIPV antibody titer also decreased to the level below the cut off level of positive result (1:100). In this case, the treatment with ozagrel hydrochloride was discontinued 12 months later, and the cat was in good condition without recurrence over 6 months.
A 7-year-old neutered male Japanese domestic cat, case 2, was admitted with abdominal enlargement. Physical examination revealed abdominal effusions. On hematological examination, leukocytosis (23,100/µl) and hyperproteinemia (8.8 g/dl) with polyclonal gammopathy were observed (Table 1) . Anti-FIPV antibody titer was 1:800 at the first admission. Radiological examination revealed peritoneal effusion (Fig. 2a) . The peritoneal fluid appeared yellow in color and sticky, and its protein concentration was 6.4 g/dl. Electrophoresis of the protein in the ascites also revealed the polyclonal gammopathy with 44.7% gamma-globulin content in the ascites. Therefore, case 2 was also diagnosed as FIP. The treatment with ozagrel hydrochloride (10 mg/kg, twice daily) and predonisolone (2 mg/kg) were initiated. After the treatment with ozagrel hydrochloride for 12 days, abdominal effusion disappeared (Fig. 2b) . The cat was in good condition for 8 months, and the level of anti-FIPV antibody titer fluctuated between 1:400 and 1:6,400. In this case, ozagrel hydrochloride treatment was discontinued 9 months later because of the nasal discharge with bleeding. After withdrawal of the treatment, abdominal effusion was recurred, and cat died eleven months after the initial admission.
We previously reported the disregulation of IL-1 production by peritoneal exudate cells obtained from ascites of cats with FIP [6, 7, 11] . Furthermore IL-6 activities were elevated in sera and ascites from cats with FIP [8] . Boudreaux et al. [2] indicated the enhanced platelet reactivity in cats experimentally infected with FIPV. It has been shown that endothelial cells synthesize platelet activating factor (PAF), after stimulation with IL-1 derived monocytes in humans [4] . PAF-activated platelets produce TxA2 and secrete bioactive substances such as serotonine, ADP, and histamine. The synergic effects of PAF with these substances are thought to enhance vascular permeability and contraction, leading to severe vascular injury [1, 4] .
The successful effects of thromboxane synthetase inhibitor (ozagrel hydrochloride) on the disease progression of FIP in cats were shown as improvement of appetite and activity, decrease of peritoneal effusion, and reduction of the leukocyte counts and serum γ-globulin level. These findings indicated vasculitis in FIP was successfully treated by ozagrel hydrochloride administration, since Tx synthetase inhibitor could reduce the platelet aggregation as well as microvascular contraction [12] . Adverse side effect of the treatment was not noted in case 1, however, it became apparent as nasal bleeding in case 2. Thus, ozagrel hydrochloride treatment was discontinued. In experimental studies with in healthy dogs on Tx synthetase inhibitor, the side effect included a slight prolongation of bleeding time and mild bruising at venipuncture site [13] . When severe hemorrhagic signs are observed, ozagrel hydrochloride treatments should be ceased. Further trials for the treatment of FIP cases with ozagrel hydrochloride should be required to establish a new treatment protocol for FIP in cats.
